Ecron Acunova(EA) would be consolidating its capabilities with TAKE’s Life Sciences brand Navitas and Intelent to form a unified brand – Navitas Life Sciences.

EA’s Clinical capabilities will now be augmented by brands such as Navitas’s technology led solutions across clinical, regulatory and safety along with Intelent’s big data and analytics expertise.

Dr Ayaaz Hussain Khan, Managing Director, Ecron Acunova, said, "Capitalising on the growth opportunities in the Life Sciences industry calls for diverse capabilities. The unification of Ecron Acunova, Navitas and Intelent will enable a seamless consolidation of capabilities in the form of Navitas Life Sciences, which will enable us to offer clients a full-service coverage of the Pharma and Biotech R&D market to carry forward our legacy of servicing patients across the world."